This news is delayed. Get access to this information before it is priced into the market with a real-time news feed for only $1. LABD, LABU - A Bad Sign For Biotech Bulls Actually, there are several warning signs for biotechnology bulls, but the focus here is on the Direxion Daily S&P Biotech Bear 3X Shares LABD 13.22%. The newly minted Direxion Daily S&P Biotech Bear 3X Shares was highlighted on August 7 with the point of that piece essentially being that biotech stocks had just come off a brutal week, which was great news for the first triple-leveraged bearish biotech ETF. Since then, LABD has climbed 17.6 percent, though as is par for the course with leveraged ETFs, that ride higher has... More